Alpha Centric Advisors LLC Ptc Therapeutics, Inc. Transaction History

Alpha Centric Advisors LLC

  • $118 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 08, 2022
SELL
$41.85 - $53.85 $732,375 - $942,375
-17,500 Closed
0 $0
Q4 2021

Feb 25, 2022
BUY
$35.36 - $41.86 $176,800 - $209,300
5,000 Added 40.0%
17,500 $697,000
Q3 2021

Mar 09, 2022
BUY
$37.01 - $44.74 $92,525 - $111,850
2,500 Added 25.0%
12,500 $465,000
Q2 2021

Mar 09, 2022
BUY
$37.95 - $49.37 $379,500 - $493,700
10,000 New
10,000 $423,000

Others Institutions Holding PTCT

# of Institutions
223
Shares Held
78.1M
Call Options Held
144K
Put Options Held
58.7K
View Full List

About PTC THERAPEUTICS, INC.

PTCT Quotes by TradingView
  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $2.81B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Alpha Centric Advisors LLC Portfolio

Follow Alpha Centric Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Centric Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Centric Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email